Effect of Muscle Fatigue on Spinal Imbalance and Motion in Lumbar Spinal Stenosis (MuscLSS)

February 28, 2025 updated by: University Hospital, Basel, Switzerland

MuscLSS: Effect of Muscle Fatigue on Spinal Imbalance and Motion in Lumbar Spinal Stenosis: Single Center Observational Pilot Study

This study assesses spinal imbalance and motion in patients with sLSS and elicits fatigue via back exercises and compares spinal imbalance and motion before and after the fatigue exercise and compares these to healthy controls, allowing to associate sLSS-specific motion patterns to paraspinal muscle fatigue.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Symptomatic lumbar spinal stenosis (sLSS) is a common syndrome affecting the human spine characterized by age related degeneration of the lumbar discs and facet joints resulting in pain, limited function and compromised quality of life. In a healthy spine, global and local spinal loads during static posture and dynamic motion will have minimal effects on the spinal canal. However, spinal loads altered by the presence of sLSS may result in further narrowing of the spinal canal and compression of the neural elements or in overloading of the already degenerated lumbar segments possibly eliciting typical pain symptoms. This study assesses spinal imbalance and motion in patients with sLSS and elicits fatigue via back exercises and compares spinal imbalance and motion before and after the fatigue exercise and compares these to healthy controls, allowing to associate sLSS-specific motion patterns to paraspinal muscle fatigue. Additional data generated using magnetic resonance tomography allows detecting and assessing differences in muscle degeneration between sLSS patients and healthy controls. Radiological images from the spine in upright position using EOS, a specialized low-dose x-ray unit will be obtained to allow the calculation of the actual clinical global and local spinal imbalance. Furthermore, this study investigates the outcome of the decompression surgery during a second study visit scheduled 1 year postoperatively. The data obtained here are pilot data that will be critical for designing a larger clinical trial and produce important information for adapting musculoskeletal spine models to simulate spinal imbalance and motion and further defining meaningful outcome parameters.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • Spine Center, University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with sLSS will be recruited at the Department of Spine Surgery at the University Hospital Basel.

Healthy participants will be recruited via advertisement on the institutional website and the University of Basel marketplace.

Description

Inclusion Criteria:for patients with sLSS

  • age > 30 years
  • BMI < 35kg/m2
  • diagnosed symptomatic lumbar spinal stenosis
  • clinical symptoms for at least 6 months
  • intermittent neurogenic claudication with limitations of their walking ability due to symptoms in the lower back and or in one or both legs
  • unsuccessful conservative treatment
  • confirmation of the LSS through MRI
  • Inclusion criteria for age-matched healthy control subjects
  • age > 30 years
  • BMI < 35kg/m2
  • Inclusion criteria for young healthy control subjects
  • 18 years ≤ age ≤ 30 years
  • BMI < 35kg/m2

Exclusion Criteria:for patients with sLSS

  • inability to provide informed consent
  • previous spine surgery
  • use of walking aids
  • other neurologic disorders affecting gait
  • MRI incompatibility
  • Exclusion criteria for age-matched healthy control subjects
  • inability to provide informed consent
  • previous spine surgery
  • history of claudications
  • use of walking aids
  • other neurological or orthopaedic conditions that may affect gait
  • MRI incompatibility
  • Exclusion criteria for young healthy control subjects
  • inability to provide informed consent
  • previous back injury; previous spine surgery
  • use of walking aids
  • current injury of any kind

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with sLSS
Patients with Symptomatic Lumbar Spinal Stenosis (n=10)
The study entails the collection of clinical, functional, radiological, and biomechanical data.
Young Controls
Young healthy control subjects (n=10)
The study entails the collection of clinical, functional, radiological, and biomechanical data.
Age-Matched Controls
Age-matched healthy control subjects (n=10)
The study entails the collection of clinical, functional, radiological, and biomechanical data.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global spinal imbalance assessed using motion capture
Time Frame: approximate duration: 30 minutes at baseline and at 1 year after decompression surgery for patients with sLSS
Global spinal imbalance calculated from markers placed on specific anatomical landmarks: electromyographic (EMG) electrode placement bilaterally on the multifidus, erector spinae (longissimus), erector spinae (iliocostalis), transversus abdominis, gluteus medius, vastus medialis, tibialis anterior and gastrocnemius medialis muscles. The curvature of the lumbar region during natural stance, natural seated posture, maximum trunk flexion, maximum trunk extension and during walking will be computed from the marker data. A cubic polynomial function will be fit to the marker positions in each time frame, approximating an S-shaped spine curvature with thoracic kyphosis and lumbar lordosis curves and the curvature of the lumbar spine will be computed for each task.
approximate duration: 30 minutes at baseline and at 1 year after decompression surgery for patients with sLSS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global spinal imbalance assessed using EOS (upright standing sagittal plane EOS images of the full body including entire spine and pelvis)
Time Frame: approximate duration: 10 minutes at baseline and at 1 year after decompression surgery for patients with sLSS
Static global and local spinal imbalance will be assessed on the EOS images as the C7 plumb line (C7PL), sagittal vertical axis (SVA) and spinosacral angle (SSA). The discrepancy between SSA and SVA are a sign of the prevalence of static compensation mechanism. The correction angle to a balanced situation will be measured using the full balance integrated method.
approximate duration: 10 minutes at baseline and at 1 year after decompression surgery for patients with sLSS
Dynamic global spinal imbalance
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Dynamic spinal imbalance will be assessed as the difference between spinal imbalance during walking compared to standing.
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Difference in global spinal imbalance between the fatigued and non-fatigued state
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
The curvature of the lumbar region between the fatigued and non-fatigued state will be computed from the marker data.
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oswestry disability index (ODI)
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Disability related to LSS will be assessed using the validated German version of the ODI. The ODI is a standardized questionnaire comprising 10 self-administered parameters quantifying the impact of low back pain on daily life
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Quality of life (EQ-5D-5L)
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Overall health will be assessed using the validated German version of the EQ-5D-5L. The EQ-5D-5L is a generic health-related instrument frequently used in clinical environments to measure quality of life. It comprises 5 questions with Likert response options and a visual analogue scale where patients are asked to rate their overall health from 0 (the worst health imaginable) to 100 (the best health imaginable).
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Muscle cross sectional area (MRI))
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS (approximate duration: 30 minutes)
For L1 to L5, the cross-sectional area (CSA) of the abdominal and paraspinal muscles on each side and the CSA of the vertebral body will be measured. The relative CSA (rCSA) and the ratio of LeanCSA to the paraspinal muscle CSA (LeanCSA/CSA) will be calculated for each level and side. This measurement of muscle degeneration (atrophy and fatty infiltration) allows quantifying abdominal and paraspinal muscle degeneration.
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS (approximate duration: 30 minutes)
Muscle fatigue, assessed as the duration of the fatigue exercise from start until termination
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS

Muscle fatigue will be quantified as the slope of the mean frequency and the change in the signal intensity during the modified Biering-Sørensen test. The starting position is the patient/client adopting a half prone lying on a plinth with the superior edge of the iliac crest at the edge of the plinth and the arms crossed over the chest.

The lower limbs are strategically stabilized with straps. The patient/client is asked to maintains the upper body in a horizontal position and the timer is started.

The test ends if the patient/client can maintain the said position for 4 minutes (240 seconds) or can no longer maintain the set position before 4 minutes elapses. The stop time is recorded.

one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Fatigue exercise duration
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Fatigue exercise duration will be recorded as the duration from start to end of the fatigue exercise.
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Local spinal imbalance
Time Frame: one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS
Local spinal imbalance will be calculated from the reflective markers positioned on the spinous processes.
one time assessment at baseline and at 1 year after decompression surgery for patients with sLSS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cordula Netzer, PD Dr. med., Spine Center, University Hospital Basel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2021

Primary Completion (Actual)

May 30, 2023

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

March 22, 2022

First Submitted That Met QC Criteria

March 31, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 28, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Spinal Stenosis

Clinical Trials on data collection

Subscribe